Cargando…
Site-Specific PEGylation of Therapeutic Proteins
The use of proteins as therapeutics has a long history and is becoming ever more common in modern medicine. While the number of protein-based drugs is growing every year, significant problems still remain with their use. Among these problems are rapid degradation and excretion from patients, thus re...
Autores principales: | Dozier, Jonathan K., Distefano, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632829/ https://www.ncbi.nlm.nih.gov/pubmed/26516849 http://dx.doi.org/10.3390/ijms161025831 |
Ejemplares similares
-
Development of a novel DDS for site-specific PEGylated proteins
por: Yoshioka, Yasuo, et al.
Publicado: (2011) -
Rapid Analysis of Protein Farnesyltransferase Substrate
Specificity Using Peptide Libraries and Isoprenoid Diphosphate Analogues
por: Wang, Yen-Chih, et al.
Publicado: (2014) -
Novel site-specific PEGylated L-asparaginase
por: Meneguetti, Giovanna Pastore, et al.
Publicado: (2019) -
Site-specific PEGylation of lidamycin and its antitumor activity
por: Li, Liang, et al.
Publicado: (2015) -
Correction: Novel site-specific PEGylated L-asparaginase
por: Meneguetti, Giovanna Pastore, et al.
Publicado: (2019)